{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T08:00:22Z","timestamp":1740124822855,"version":"3.37.3"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,4,5]],"date-time":"2018-04-05T00:00:00Z","timestamp":1522886400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Genes Immun"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1038\/s41435-018-0022-3","type":"journal-article","created":{"date-parts":[[2018,4,4]],"date-time":"2018-04-04T14:03:41Z","timestamp":1522850621000},"page":"198-206","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Evaluation of the TLR negative regulatory network in CVID patients"],"prefix":"10.1038","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1055-9305","authenticated-orcid":false,"given":"Roozbeh","family":"Sanaei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nima","family":"Rezaei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asghar","family":"Aghamohammadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali-Akbar","family":"Delbandi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shahram","family":"Teimourian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reza","family":"Yazdani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Parsova","family":"Tavasolian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatemeh","family":"Kiaee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nader","family":"Tajik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,4,5]]},"reference":[{"key":"22_CR1","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1586\/1744666X.2014.958469","volume":"10","author":"A Aghamohammadi","year":"2014","unstructured":"Aghamohammadi A, Abolhassani H, Latif A, Tabassomi F, Shokuhfar T, Torabi Sagvand B, et al. Long-term evaluation of a historical cohort of Iranian common variable immunodeficiency patients. Expert Rev Clin Immunol. 2014;10:1405\u201317.","journal-title":"Expert Rev Clin Immunol"},{"key":"22_CR2","first-page":"544","volume":"19","author":"M Mokhtari","year":"2016","unstructured":"Mokhtari M, Shakeri A, Mirminachi B, Abolhassani H, Yazdani R, Grimbacher B, et al. Important factors influencing severity of common variable immunodeficiency. Arch Iran Med. 2016;19:544\u201350.","journal-title":"Arch Iran Med"},{"key":"22_CR3","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1080\/1744666X.2016.1224664","volume":"13","author":"G Azizi","year":"2017","unstructured":"Azizi G, Abolhassani H, Asgardoon MH, Alinia T, Yazdani R, Mohammadi J, et al. Autoimmunity in common variable immunodeficiency: epidemiology, pathophysiology and management. Expert Rev Clin Immunol. 2017;13:101\u201315.","journal-title":"Expert Rev Clin Immunol"},{"key":"22_CR4","doi-asserted-by":"publisher","first-page":"209","DOI":"10.18176\/jiaci.0062","volume":"26","author":"R Yazdani","year":"2016","unstructured":"Yazdani R, Heydari A, Azizi G, Abolhassani H, Aghamohammadi A. Asthma and allergic diseases in a selected group of patients with common variable immunodeficiency. J Investig Allergol Clin Immunol. 2016;26:209\u201311.","journal-title":"J Investig Allergol Clin Immunol"},{"key":"22_CR5","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3109\/08830185.2015.1136306","volume":"35","author":"R Yazdani","year":"2016","unstructured":"Yazdani R, Abolhassani H, Rezaei N, Azizi G, Hammarstrom L, Aghamohammadi A. Evaluation of known defective signaling-associated molecules in patients who primarily diagnosed as common variable immunodeficiency. Int Rev Immunol. 2016;35:7\u201324.","journal-title":"Int Rev Immunol"},{"key":"22_CR6","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.aller.2016.07.001","volume":"45","author":"R Yazdani","year":"2017","unstructured":"Yazdani R, Seify R, Ganjalikhani-Hakemi M, Abolhassani H, Eskandari N, Golsaz-Shirazi F, et al. Comparison of various classifications for patients with common variable immunodeficiency (CVID) using measurement of B-cell subsets. Allergol Immunopathol. 2017;45:183\u201392.","journal-title":"Allergol Immunopathol"},{"key":"22_CR7","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.clim.2016.09.009","volume":"175","author":"R Yazdani","year":"2017","unstructured":"Yazdani R, Ganjalikhani-Hakemi M, Esmaeili M, Abolhassani H, Vaeli S, Rezaei A, et al. Impaired Akt phosphorylation in B-cells of patients with common variable immunodeficiency. Clin Immunol. 2017;175:124\u201332.","journal-title":"Clin Immunol"},{"key":"22_CR8","doi-asserted-by":"publisher","first-page":"233","DOI":"10.18176\/jiaci.0069","volume":"26","author":"G Azizi","year":"2016","unstructured":"Azizi G, Rezaei N, Kiaee F, Tavakolinia N, Yazdani R, Mirshafiey A, et al. T-cell abnormalities in common variable immunodeficiency. J Investig Allergol Clin Immunol. 2016;26:233\u201343.","journal-title":"J Investig Allergol Clin Immunol"},{"key":"22_CR9","doi-asserted-by":"publisher","first-page":"3399","DOI":"10.4049\/jimmunol.180.5.3399","volume":"180","author":"A Pegu","year":"2008","unstructured":"Pegu A, Qin S, Fallert Junecko BA, Nisato RE, Pepper MS, Reinhart TA. Human lymphatic endothelial cells express multiple functional TLRs. J Immunol. 2008;180:3399\u2013405.","journal-title":"J Immunol"},{"key":"22_CR10","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1586\/1744666X.2016.1114885","volume":"12","author":"L Sharifi","year":"2016","unstructured":"Sharifi L, Mirshafiey A, Rezaei N, Azizi G, Magaji Hamid K, Amirzargar AA, et al. The role of Toll-like receptors in B-cell development and immunopathogenesis of common variable immunodeficiency. Expert Rev Clin Immunol. 2016;12:195\u2013207.","journal-title":"Expert Rev Clin Immunol"},{"key":"22_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12016-015-8473-z","volume":"50","author":"JQ Chen","year":"2016","unstructured":"Chen JQ, Szodoray P, Zeher M. Toll-like receptor pathways in autoimmune diseases. Clin Rev Allergy Immunol. 2016;50:1\u201317.","journal-title":"Clin Rev Allergy Immunol"},{"key":"22_CR12","doi-asserted-by":"publisher","first-page":"515","DOI":"10.2147\/IJN.S114477","volume":"12","author":"N Hanagata","year":"2017","unstructured":"Hanagata N. CpG oligodeoxynucleotide nanomedicines for the prophylaxis or treatment of cancers, infectious diseases, and allergies. Int J Nanomed. 2017;12:515\u201331.","journal-title":"Int J Nanomed"},{"key":"22_CR13","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1038\/nri3713","volume":"14","author":"NJ Gay","year":"2014","unstructured":"Gay NJ, Symmons MF, Gangloff M, Bryant CE. Assembly and localization of Toll-like receptor signalling complexes. Nat Rev Immunol. 2014;14:546\u201358.","journal-title":"Nat Rev Immunol"},{"key":"22_CR14","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1189\/jlb.2MR0316-117RR","volume":"100","author":"CA Leifer","year":"2016","unstructured":"Leifer CA, Medvedev AE. Molecular mechanisms of regulation of Toll-like receptor signaling. J Leukoc Biol. 2016;100:927\u201341.","journal-title":"J Leukoc Biol"},{"key":"22_CR15","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/nri1630","volume":"5","author":"FY Liew","year":"2005","unstructured":"Liew FY, Xu D, Brint EK, O\u2019Neill LAJ. Negative regulation of Toll-like receptor-mediated immune responses. Nat Rev Immunol. 2005;5:446\u201358.","journal-title":"Nat Rev Immunol"},{"key":"22_CR16","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/S0092-8674(02)00827-9","volume":"110","author":"K Kobayashi","year":"2002","unstructured":"Kobayashi K, Hernandez LD, Galan JE, Janeway CA Jr., Medzhitov R, Flavell RA. IRAK-M is a negative regulator of Toll-like receptor signaling. Cell. 2002;110:191\u2013202.","journal-title":"Cell"},{"key":"22_CR17","doi-asserted-by":"publisher","DOI":"10.4081\/idr.2010.e9","volume":"2","author":"LL Hubbard","year":"2010","unstructured":"Hubbard LL, Moore BB. IRAK-M regulation and function in host defense and immune homeostasis. Infect Dis Rep. 2010;2:e9.","journal-title":"Infect Dis Rep"},{"key":"22_CR18","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/S0092-8674(02)00827-9","volume":"110","author":"K Kobayashi","year":"2002","unstructured":"Kobayashi K, Hernandez LD, Gal\u00e1n JE, Janeway CA, Medzhitov R, Flavell RA. IRAK-M is a negative regulator of Toll-like receptor signaling. Cell. 2002;110:191\u2013202.","journal-title":"Cell"},{"key":"22_CR19","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.niox.2004.04.007","volume":"10","author":"C Fresno del","year":"2004","unstructured":"del Fresno C, Gomez-Garcia L, Caveda L, Escoll P, Arnalich F, Zamora R, et al. Nitric oxide activates the expression of IRAK-M via the release of TNF-alpha in human monocytes. Nitric Oxide. 2004;10:213\u201320.","journal-title":"Nitric Oxide"},{"key":"22_CR20","doi-asserted-by":"publisher","first-page":"7110","DOI":"10.4049\/jimmunol.179.10.7110","volume":"179","author":"C \u2018t Veer van","year":"2007","unstructured":"van \u2018t Veer C, van den Pangaart PS, van Zoelen MA, de Kruif M, Birjmohun RS, Stroes ES, et al. Induction of IRAK-M is associated with lipopolysaccharide tolerance in a human endotoxemia model. J Immunol. 2007;179:7110\u201320.","journal-title":"J Immunol"},{"key":"22_CR21","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/S1471-4906(03)00139-X","volume":"24","author":"T Fukao","year":"2003","unstructured":"Fukao T, Koyasu S. PI3K and negative regulation of TLR signaling. Trends Immunol. 2003;24:358\u201363.","journal-title":"Trends Immunol"},{"key":"22_CR22","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1159\/000158541","volume":"1","author":"J Su","year":"2009","unstructured":"Su J, Zhang T, Tyson J, Li L. The interleukin-1 receptor-associated kinase M selectively inhibits the alternative, instead of the classical NF\u03baB pathway. J Innate Immun. 2009;1:164\u201374.","journal-title":"J Innate Immun"},{"key":"22_CR23","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1016\/j.bcp.2010.06.044","volume":"80","author":"L Verstrepen","year":"2010","unstructured":"Verstrepen L, Verhelst K, Van Loo G, Carpentier I, Ley SC, Beyaert R. Expression, biological activities and mechanisms of action of A20 (TNFAIP3). Biochem Pharmacol. 2010;80:2009\u201320.","journal-title":"Biochem Pharmacol"},{"key":"22_CR24","volume":"5","author":"H Luo","year":"2015","unstructured":"Luo H, Liu Y, Li Q, Liao L, Sun R, Liu X, et al. A20 regulates IL-1-induced tolerant production of CXC chemokines in human mesangial cells via inhibition of MAPK signaling. Sci Rep. 2015;5:5.","journal-title":"Sci Rep"},{"key":"22_CR25","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.jaci.2016.04.043","volume":"139","author":"B Keller","year":"2017","unstructured":"Keller B, Cseresnyes Z, Stumpf I, Wehr C, Fliegauf M, Bulashevska A, et al. Disturbed canonical nuclear factor of kappa light chain signaling in B cells of patients with common variable immunodeficiency. J Allergy Clin Immunol. 2017;139:220\u201331.e8.","journal-title":"J Allergy Clin Immunol"},{"key":"22_CR26","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.ajhg.2015.07.008","volume":"97","author":"M Fliegauf","year":"2015","unstructured":"Fliegauf M, Bryant VL, Frede N, Slade C, Woon ST, Lehnert K, et al. Haploinsufficiency of the NF-kappaB1 subunit p50 in common variable immunodeficiency. Am J Hum Genet. 2015;97:389\u2013403.","journal-title":"Am J Hum Genet"},{"issue":"Supplement C","key":"22_CR27","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.clim.2016.11.014","volume":"175","author":"E Taraldsrud","year":"2017","unstructured":"Taraldsrud E, Aukrust P, J\u00f8rgensen S, Lingj\u00e6rde OC, Olweus J, Myklebust JH, et al. Patterns of constitutively phosphorylated kinases in B cells are associated with disease severity in common variable immunodeficiency. Clin Immunol. 2017;175(Supplement C):69\u201374.","journal-title":"Clin Immunol"},{"key":"22_CR28","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1002\/eji.201444795","volume":"45","author":"NT Xuan","year":"2015","unstructured":"Xuan NT, Wang X, Nishanth G, Waisman A, Borucki K, Isermann B, et al. A20 expression in dendritic cells protects mice from LPS-induced mortality. Eur J Immunol. 2015;45:818\u201328.","journal-title":"Eur J Immunol"},{"key":"22_CR29","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.immuni.2011.05.013","volume":"35","author":"M Kool","year":"2011","unstructured":"Kool M, van Loo G, Waelput W, De Prijck S, Muskens F, Sze M, et al. The ubiquitin-editing protein A20 prevents dendritic cell activation, recognition of apoptotic cells, and systemic autoimmunity. Immunity. 2011;35:82\u201396.","journal-title":"Immunity"},{"key":"22_CR30","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1084\/jem.20071108","volume":"205","author":"EE Turer","year":"2008","unstructured":"Turer EE, Tavares RM, Mortier E, Hitotsumatsu O, Advincula R, Lee B, et al. Homeostatic MyD88-dependent signals cause lethal inflammation in the absence of A20. J Exp Med. 2008;205:451\u201364.","journal-title":"J Exp Med"},{"key":"22_CR31","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1038\/nature02794","volume":"430","author":"IE Wertz","year":"2004","unstructured":"Wertz IE, O\u2019rourke KM, Zhou H, Eby M, Aravind L, Seshagiri S, et al. De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-\u03baB signalling. Nature. 2004;430:694\u20139.","journal-title":"Nature"},{"key":"22_CR32","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1007\/s00210-012-0765-8","volume":"385","author":"K Murakami","year":"2012","unstructured":"Murakami K, Suzuki C, Kobayashi F, Nakano A, Fujii A, Sakai K, et al. Intravenous immunoglobulin preparation attenuates LPS-induced production of pro-inflammatory cytokines in human monocytic cells by modulating TLR4-mediated signaling pathways. Naunyn Schmiede Arch Pharmacol. 2012;385:891\u20138.","journal-title":"Naunyn Schmiede Arch Pharmacol"},{"key":"22_CR33","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1111\/j.1365-2249.2012.04620.x","volume":"169","author":"RR Barbosa","year":"2012","unstructured":"Barbosa RR, Silva SP, Silva SL, Tendeiro R, Melo AC, Pedro E, et al. Monocyte activation is a feature of common variable immunodeficiency irrespective of plasma lipopolysaccharide levels. Clin Exp Immunol. 2012;169:263\u201372.","journal-title":"Clin Exp Immunol"},{"key":"22_CR34","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1111\/j.1365-2249.2012.04655.x","volume":"170","author":"J Litzman","year":"2012","unstructured":"Litzman J, Nechv\u00e1talov\u00e1 J, Xu J, Tich\u00e1 O, Vlkov\u00e1 M, Hel Z. Chronic immune activation in common variable immunodeficiency (CVID) is associated with elevated serum levels of soluble CD14 and CD25 but not endotoxaemia. Clin & Exp Immunol. 2012;170:321\u201332.","journal-title":"Clin & Exp Immunol"},{"key":"22_CR35","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.1084\/jem.20140039","volume":"211","author":"M Perreau","year":"2014","unstructured":"Perreau M, Vigano S, Bellanger F, Pellaton C, Buss G, Comte D, et al. Exhaustion of bacteria-specific CD4 T cells and microbial translocation in common variable immunodeficiency disorders. J Exp Med. 2014;211:2033\u201345.","journal-title":"J Exp Med"},{"key":"22_CR36","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1038\/ng.202","volume":"40","author":"SL Musone","year":"2008","unstructured":"Musone SL, Taylor KE, Lu TT, Nititham J, Ferreira RC, Ortmann W, et al. Multiple polymorphisms in the TNFAIP3 region are independently associated with systemic lupus erythematosus. Nat Genet. 2008;40:1062\u20134.","journal-title":"Nat Genet"},{"key":"22_CR37","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/nature13322","volume":"512","author":"LV Walle","year":"2014","unstructured":"Walle LV, Van Opdenbosch N, Jacques P, Fossoul A, Verheugen E, Vogel P, et al. Negative regulation of the NLRP3 inflammasome by A20 protects against arthritis. Nature. 2014;512:69\u201373.","journal-title":"Nature"},{"key":"22_CR38","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1080\/00365520601114024","volume":"42","author":"RK Weersma","year":"2007","unstructured":"Weersma RK, Oostenbrug LE, Nolte IM, Van Der Steege G, Oosterom E, Van Dullemen HM, et al. Association of interleukin-1 receptor-associated kinase M (IRAK-M) and inflammatory bowel diseases. Scand J Gastroenterol. 2007;42:827\u201333.","journal-title":"Scand J Gastroenterol"},{"key":"22_CR39","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1083\/jcb.200304135","volume":"164","author":"R Palumbo","year":"2004","unstructured":"Palumbo R, Sampaolesi M, De Marchis F, Tonlorenzi R, Colombetti S, Mondino A, et al. Extracellular HMGB1, a signal of tissue damage, induces mesoangioblast migration and proliferation. J Cell Biol. 2004;164:441\u20139.","journal-title":"J Cell Biol"},{"key":"22_CR40","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.coi.2005.11.012","volume":"18","author":"LA O\u2019Neill","year":"2006","unstructured":"O\u2019Neill LA. How Toll-like receptors signal: what we know and what we don\u2019t know. Curr Opin Immunol. 2006;18:3\u20139.","journal-title":"Curr Opin Immunol"},{"key":"22_CR41","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/nri1391","volume":"4","author":"S Akira","year":"2004","unstructured":"Akira S, Takeda K. Toll-like receptor signalling. Nat Rev Immunol. 2004;4:499\u2013511.","journal-title":"Nat Rev Immunol"},{"key":"22_CR42","doi-asserted-by":"publisher","first-page":"34592","DOI":"10.1074\/jbc.M604019200","volume":"281","author":"C Fearns","year":"2006","unstructured":"Fearns C, Pan Q, Mathison JC, Chuang T-H. Triad3A regulates ubiquitination and proteasomal degradation of RIP1 following disruption of Hsp90 binding. J Biol Chem. 2006;281:34592\u2013600.","journal-title":"J Biol Chem"},{"key":"22_CR43","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.coi.2009.12.002","volume":"22","author":"AF McGettrick","year":"2010","unstructured":"McGettrick AF, O\u2019Neill LAJ. Localisation and trafficking of Toll-like receptors: an important mode of regulation. Curr Opin Immunol. 2010;22:20\u20137.","journal-title":"Curr Opin Immunol"},{"key":"22_CR44","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.4049\/jimmunol.176.3.1978","volume":"176","author":"C Cunningham-Rundles","year":"2006","unstructured":"Cunningham-Rundles C, Radigan L, Knight AK, Zhang L, Bauer L, Nakazawa A. TLR9 activation is defective in common variable immune deficiency. J Immunol. 2006;176:1978\u201387.","journal-title":"J Immunol"},{"key":"22_CR45","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.jaci.2009.05.019","volume":"124","author":"EY Joyce","year":"2009","unstructured":"Joyce EY, Knight AK, Radigan L, Marron TU, Zhang L, Sanchez-Ram\u00f3n S, et al. Toll-like receptor 7 and 9 defects in common variable immunodeficiency. J Allergy Clin Immunol. 2009;124:349\u201356. e3.","journal-title":"J Allergy Clin Immunol"},{"key":"22_CR46","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1007\/s10875-011-9602-y","volume":"32","author":"EY Joyce","year":"2012","unstructured":"Joyce EY, Zhang L, Radigan L, Sanchez-Ramon S, Cunningham-Rundles C. TLR-mediated B cell defects and IFN-\u03b1 in common variable immunodeficiency. J Clin Immunol. 2012;32:50\u201360.","journal-title":"J Clin Immunol"}],"container-title":["Genes & Immunity"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41435-018-0022-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41435-018-0022-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41435-018-0022-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:14:57Z","timestamp":1684617297000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41435-018-0022-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,5]]},"references-count":46,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["22"],"URL":"https:\/\/doi.org\/10.1038\/s41435-018-0022-3","relation":{},"ISSN":["1466-4879","1476-5470"],"issn-type":[{"type":"print","value":"1466-4879"},{"type":"electronic","value":"1476-5470"}],"subject":[],"published":{"date-parts":[[2018,4,5]]},"assertion":[{"value":"13 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}